Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score.
作者信息
Yu Zhi, Wuttke Matthias
机构信息
Program of Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Masschusetts, USA.
Institute of Genetic Epidemiology, Department of Biometry, Epidemiology and Medical Bioinformatics, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg, Germany.
出版信息
Kidney Int. 2022 Nov;102(5):954-955. doi: 10.1016/j.kint.2022.08.004. Epub 2022 Aug 17.
Abstract
摘要
相似文献
1
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score.纳入载脂蛋白L1（APOL1）等位基因并进行血统调整可提高全基因组多基因慢性肾脏病（CKD）评分。
Kidney Int. 2022 Nov;102(5):954-955. doi: 10.1016/j.kint.2022.08.004. Epub 2022 Aug 17.
2
Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes.APOL1高风险基因型个体中慢性肾脏病的全基因组多基因风险评分
Clin J Am Soc Nephrol. 2024 Mar 1;19(3):374-376. doi: 10.2215/CJN.0000000000000379. Epub 2023 Nov 14.
3
Genome-wide polygenic score to predict chronic kidney disease across ancestries.基于全基因组的多基因风险评分预测不同种族人群的慢性肾脏病。
Nat Med. 2022 Jul;28(7):1412-1420. doi: 10.1038/s41591-022-01869-1. Epub 2022 Jun 16.
4
Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.南非黑人高血压相关性慢性肾脏病患者载脂蛋白L1基因变异的低患病率
Clin Nephrol. 2019 Jan;91(1):40-47. doi: 10.5414/CN109432.
5
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.载脂蛋白L1（APOL1）等位基因与慢性肾脏病（CKD）进展相关性的潜在修饰因素研究
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.
6
APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.混合血统南非人中的载脂蛋白L1（APOL1）基因变异、慢性肾病与高血压
BMC Genet. 2015 Jun 26;16:69. doi: 10.1186/s12863-015-0228-6.
7
Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles.APOL3 蛋白截断变异与 APOL1 风险等位基因的共显性作用增加了慢性肾脏病的风险。
JCI Insight. 2024 Oct 8;9(19):e181238. doi: 10.1172/jci.insight.181238.
8
APOL1 risk allele variants are absent in Indian patients with chronic kidney disease.慢性肾病印度患者中不存在APOL1风险等位基因变体。
Kidney Int. 2016 Oct;90(4):906-7. doi: 10.1016/j.kint.2016.07.026.
9
An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.APOL1 风险基因型与非裔美国人早产队列研究。
Nephrol Dial Transplant. 2017 Dec 1;32(12):2051-2058. doi: 10.1093/ndt/gfw317.
10
Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.具有高危 APOL1 基因型的 CKD 患者的临床和遗传特征。
J Am Soc Nephrol. 2023 May 1;34(5):909-919. doi: 10.1681/ASN.0000000000000094. Epub 2023 Feb 9.
引用本文的文献
1
Single-Ancestry versus Multi-Ancestry Polygenic Risk Scores for CKD in Black American Populations.美国黑人人群中慢性肾脏病的单祖先与多祖先多基因风险评分
J Am Soc Nephrol. 2024 Nov 1;35(11):1558-1569. doi: 10.1681/ASN.0000000000000437. Epub 2024 Jul 29.
本文引用的文献
1
Genome-wide polygenic score to predict chronic kidney disease across ancestries.基于全基因组的多基因风险评分预测不同种族人群的慢性肾脏病。
Nat Med. 2022 Jul;28(7):1412-1420. doi: 10.1038/s41591-022-01869-1. Epub 2022 Jun 16.
2
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病中的遗传学：KDIGO（改善全球肾脏病预后组织）争议会议的结论。
Kidney Int. 2022 Jun;101(6):1126-1141. doi: 10.1016/j.kint.2022.03.019. Epub 2022 Apr 20.
3
Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases.多基因风险评分与肾功能及其与循环蛋白质组学的关系，以及与新发肾脏疾病的关系。
J Am Soc Nephrol. 2021 Dec 1;32(12):3161-3173. doi: 10.1681/ASN.2020111599.
4
A catalog of genetic loci associated with kidney function from analyses of a million individuals.一项对 100 万人进行的分析显示，与肾功能相关的遗传基因座目录。
Nat Genet. 2019 Jun;51(6):957-972. doi: 10.1038/s41588-019-0407-x. Epub 2019 May 31.
5
The illusion of polygenic disease risk prediction.多基因疾病风险预测的幻象。
Genet Med. 2019 Aug;21(8):1705-1707. doi: 10.1038/s41436-018-0418-5. Epub 2019 Jan 12.
6
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.对 480,000 名成年人的冠心病的基因组风险预测：对一级预防的影响。
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893. doi: 10.1016/j.jacc.2018.07.079.
7
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.全基因组多基因疾病风险评分可识别出与单基因突变风险相当的个体。
Nat Genet. 2018 Sep;50(9):1219-1224. doi: 10.1038/s41588-018-0183-z. Epub 2018 Aug 13.
8
The personal and clinical utility of polygenic risk scores.多基因风险评分的个体和临床效用。
Nat Rev Genet. 2018 Sep;19(9):581-590. doi: 10.1038/s41576-018-0018-x.
Zotero 插件